Our results showing that LRRK2 knock out decreases aggregation of α-syn raise the possibility that these inhibitors may be efficacious in sporadic PD and not only in PD cases caused by LRRK2 mutations. This evidence concerns the gene LRRK2 and Parkinson disease.